Cargando…

Mechanistic modelling of Virchows triad to assess thrombogenicity and stroke risk in atrial fibrillation patients

BACKGROUND: Atrial fibrillation (AF) is responsible for almost one third of all strokes, with the left atrial appendage (LAA) being the primary thromboembolic source due to localised stimulation of prothrombotic mechanisms; blood stasis, hypercoagulability and endothelial damage, known as Virchow�...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qureshi, A, Balmus, M, Lip, G Y H, Williams, S, Nordsletten, D A, Aslanidi, O, De Vecchi, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779765/ http://dx.doi.org/10.1093/ehjdh/ztac076.2788

Ejemplares similares

Imaging and biophysical modelling of thrombogenic mechanisms in atrial fibrillation and stroke
por: Qureshi, Ahmed, et al.
Publicado: (2023)

Atrial Cardiomyopathy: An Unexplored Limb of Virchow's Triad for AF Stroke Prophylaxis
por: Darlington, Ashley, et al.
Publicado: (2020)

Permanent left atrial thrombi after multiple atrial fibrillation ablations: Acquired Virchow’s triad?
por: Ali, Saif, et al.
Publicado: (2022)

Virchow’s Triad and the Role of Thrombosis in COVID-Related Stroke
por: Gonzalez-Gonzalez, Francisco J., et al.
Publicado: (2021)

Recent-onset atrial fibrillation: a study exploring the elements of Virchow’s triad after cardioversion
por: Arvanitis, Panagiotis, et al.
Publicado: (2021)

Extracellular Vesicles and Thrombogenicity in Atrial Fibrillation
por: Berezin, Alexander E., et al.
Publicado: (2022)

Can artificial intelligence prediction of successful atrial fibrillation catheter ablation therapy be interpretable?
por: Ogbomo-Harmitt, S, et al.
Publicado: (2022)

COVID‐19, thromboembolic risk, and Virchow's triad: Lesson from the past
por: Mehta, Jawahar L., et al.
Publicado: (2020)

The Pathophysiology of Portal Vein Thrombosis in Cirrhosis: Getting Deeper into Virchow’s Triad
por: Anton, Aina, et al.
Publicado: (2022)

COVID‐19, Virchow's triad and thromboembolic risk in obese pregnant women
por: Carbillon, Lionel, et al.
Publicado: (2021)

Antiplatelet Therapy Combinations and Thrombogenicity in Patients with Non-Valvular Atrial Fibrillation
por: Park, Yongwhi, et al.
Publicado: (2017)

Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad
por: Ahmed, Sakir, et al.
Publicado: (2020)

Atrial Heterogeneity Generates Re-entrant Substrate during Atrial Fibrillation and Anti-arrhythmic Drug Action: Mechanistic Insights from Canine Atrial Models
por: Varela, Marta, et al.
Publicado: (2016)

Prevalence, predictors and management of left atrial appendage thrombogenic milieu in atrial fibrillation with low thromboembolic risk
por: Qiao, Yu, et al.
Publicado: (2023)

Letter in response to “COVID‐19, Virchow's triad and thromboembolic risk in obese pregnant women”
por: Calcaterra, Giuseppe, et al.
Publicado: (2021)

mHealth based patient-centered self-management reduces the burden and episodes of atrial fibrillation
por: Guo, Y, et al.
Publicado: (2022)

Effects of Angiotensin-II Receptor Blocker on Inhibition of Thrombogenicity in a Canine Atrial Fibrillation Model
por: Choi, Jong-Il, et al.
Publicado: (2016)

Concepts of stroke before and after Virchow.
por: Schiller, F
Publicado: (1970)

Emerging Tools for Stroke Prevention in Atrial Fibrillation
por: Voukalis, Christos, et al.
Publicado: (2016)

Stroke Prevention in Atrial Fibrillation: Where are We Now?
por: Ahmad, Yousif, et al.
Publicado: (2012)

Stroke and Bleeding Risk in Atrial Fibrillation
por: Senoo, Keitaro, et al.
Publicado: (2014)

COVID-19 Presenting as Major Thromboembolic Events: Virchow’s Triad Revisited and Clinical Considerations of Therapeutic Anticoagulation
por: Zheng, Haoyi, et al.
Publicado: (2020)

Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies
por: Ding, Wern Yew, et al.
Publicado: (2020)

Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal
por: Lane, Deirdre A, et al.
Publicado: (2020)

Virchow
Publicado: (1902)

Modeling Left Atrial Flow, Energy, Blood Heating Distribution in Response to Catheter Ablation Therapy
por: Dillon-Murphy, Desmond, et al.
Publicado: (2018)

Mechanistic targets for the ablation of atrial fibrillation
por: Zaman, Junaid A.B., et al.
Publicado: (2017)

Stroke Prevention in Atrial Fibrillation: Concepts and Controversies
por: Ahmad, Yousif, et al.
Publicado: (2012)

Stroke prevention in atrial fibrillation: comparison of recent international guidelines
por: Chao, Tze-Fan, et al.
Publicado: (2020)

Reinforcement Learning to Improve Image-Guidance of Ablation Therapy for Atrial Fibrillation
por: Muizniece, Laila, et al.
Publicado: (2021)

Frequent premature atrial contractions as a signalling marker of atrial cardiomyopathy, incident atrial fibrillation, and stroke
por: Farinha, José Maria, et al.
Publicado: (2022)

The Gymnasium at the Virchow Krankenhaus
por: Laqueur, A.
Publicado: (1913)

Atrial inflammation and microvascular thrombogenicity are increased in deceased COVID-19 patients()
por: Wu, Linghe, et al.
Publicado: (2023)

Rudolf Virchow: An Appreciation
por: Reed, Charles A. L.
Publicado: (1903)

Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients
por: Li, Yan-Guang, et al.
Publicado: (2018)

Rudolf Virchow Fund
por: Reed, Charles A. L., et al.
Publicado: (1901)

Rudolf Virchow
por: Schultz, Myron
Publicado: (2008)

Virchow and Koch
Publicado: (1891)

Rudolf Virchow
Publicado: (1891)

Professor Virchow
Publicado: (1898)

Cannot write session to /tmp/vufind_sessions/sess_8vdidmtfu8u52rmtnmbvaskhrg